Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/02/031432
CTRI/2021/02/031432
Completed
Phase 3

Advanced Platelet Rich Fibrin With and Without Intra Marrow Penetration in the Treatment of Periodontal Intrabony Defects: A Randomised Control Trial

parth sharma0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K053- Chronic periodontitis

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
parth sharma
Enrollment
20
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 6, 2020
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
parth sharma

Eligibility Criteria

Inclusion Criteria

  • •Age group of 22 to 60 years.
  • •Probing pocket depth ââ?°Â¥ 5mm.
  • •Clinical attachment loss ââ?°Â¥3mm.
  • •Presence of 2\-3 walled defect with radiographic depth \> 4mm

Exclusion Criteria

  • •Systemically compromised patients.
  • •Patients who are on medications that could interfere with wound healing.
  • •Patients with grade III mobility.
  • •Chronic smokers and alcoholics.
  • •Pregnant and lactating females.
  • •Patients who had undergone periodontal surgery with in a period of last 1 year.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
se of Aspirin in gum diseasesHealth Condition 1: null- Chronic Generalised Periodontitis With Mandibular Grade-II Furcation Defects
CTRI/2018/04/013337Self30
Recruiting
Phase 4
Comparison of Platelet-Rich Fibrin in combination with bone graft and bone graft alone in treatment of periodontal bone loss.Health Condition 1: null- Chronic Periodontitis Patients
CTRI/2017/02/007796one20
Not yet recruiting
Phase 4
A Comparative evaluation of Platelet Rich Fibrin Matrix (PRFM) AND Coronally Advanced Flap(CAF) with and without Peripheral Blood Mesenchymal Stem Cells (PBMSCs) in the surgical management of Gingival Recession Type 1 – A Split-mouth Randomised Controlled Trial.Health Condition 1: K060- Gingival recession
CTRI/2024/02/062289DR JEEVIKA A DAS
Not yet recruiting
Phase 4
Comparision of platelet concentrate obtained from patient own blood and amniotic layer which is is the inner layer of the unborn baby in the treatment of gums that pulls away from the teeth exposing the roots underneath
CTRI/2024/03/063451Dr Prachi Jain
Completed
Phase 2
A study to test different treatment options in patients with receding gums.
CTRI/2017/03/007988Singad Dental College and Hospital24